Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ASTRONICS CORPATRO · Entity 4200 | Director | August 25, 2026 | August 26, 2026 |
| CIMPRESS plcCMPR · Entity 4457 | Director · CEO, Chairman | September 11, 2026 | September 15, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ASTRONICS CORP
Report date August 25, 2026 · Filed August 26, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| $.01 PV Com StkSEC Table I · non-derivative | IndirectNote | 76,000 |
Reported balance
After 2026-08-25 transaction · row 4
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 4 · 2026-08-25 · Conversion · Acquired 76,000 · Balance 76,000 F2: Conversion of 76,000 Class B shares held by Boston & Saranac LLC on August 25, 2026. F3: The direct owner is Boston & Saranac LLC, a Delaware limited liability company ("Boston & Saranac"). Boston & Saranac is 100% owned by a trust whose beneficiaries are the Reporting Person and his spouse |
| $.01 PV CL B STKSEC Table I · non-derivative | IndirectNote | 173,838 |
Reported balance
After 2026-08-25 transaction · row 5
Holding and transaction disclosures are not merged.
1 source rowRow 5 · 2026-08-25 · Conversion · Disposed 76,000 · Balance 173,838 F2: Conversion of 76,000 Class B shares held by Boston & Saranac LLC on August 25, 2026. F3: The direct owner is Boston & Saranac LLC, a Delaware limited liability company ("Boston & Saranac"). Boston & Saranac is 100% owned by a trust whose beneficiaries are the Reporting Person and his spouse |
| $.01 PV CL B STKSEC Table I · non-derivative | IndirectNote | 248,263 |
Reported balance
Holding disclosure · report date 2026-08-25 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 248,263 F1: Reporting Person is one of multiple potential beneficiaries to the direct owner of these shares, which is a trust (EAK & KRK Trust U/A/D 10-15-97 FBO Elizabeth A. Keane). The entire amount of the trust's interest is reported on this form, however the Reporting Person's proportionate interest is below 25%. |
| $.01 PV Com StkSEC Table I · non-derivative | Direct | 13,934 |
Reported balance
Holding disclosure · report date 2026-08-25 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 13,934 |
| $.01 PV CL B STKSEC Table I · non-derivative | Direct | 2,786 |
Reported balance
Holding disclosure · report date 2026-08-25 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 2,786 |
Filing footnotes · ownership attribution and instrument terms
F1: Reporting Person is one of multiple potential beneficiaries to the direct owner of these shares, which is a trust (EAK & KRK Trust U/A/D 10-15-97 FBO Elizabeth A. Keane). The entire amount of the trust's interest is reported on this form, however the Reporting Person's proportionate interest is below 25%.
F2: Conversion of 76,000 Class B shares held by Boston & Saranac LLC on August 25, 2026.
F3: The direct owner is Boston & Saranac LLC, a Delaware limited liability company ("Boston & Saranac"). Boston & Saranac is 100% owned by a trust whose beneficiaries are the Reporting Person and his spouse
CIMPRESS plc
Report date September 11, 2026 · Filed September 15, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary SharesSEC Table I · non-derivative | Direct | 91,167 |
Ending reported balance
After 2026-09-11 transaction · row 3
3 source rows · reconciled sequenceRow 1 · 2026-09-11 · Sale · Disposed 7,901 · Balance 95,266 F1: Reflects weighted-average sale price (per share prices actually received ranged from $84.17 to $84.99). Upon appropriate request, the reporting person will provide information regarding the number of shares sold at each price within the range. Row 2 · 2026-09-11 · Sale · Disposed 3,793 · Balance 91,473 F2: Reflects weighted-average sale price (per share prices actually received ranged from $85.00 to $85.96). Upon appropriate request, the reporting person will provide information regarding the number of shares sold at each price within the range. Row 3 · 2026-09-11 · Sale · Disposed 306 · Balance 91,167 F3: Reflects weighted-average sale price (per share prices actually received ranged from $86.04 to $86.22). Upon appropriate request, the reporting person will provide information regarding the number of shares sold at each price within the range. |
| Ordinary SharesSEC Table I · non-derivative | IndirectBy Second Delaware 2003, LLC | 769,288 |
Reported balance
After 2026-09-11 transaction · row 4
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 4 · 2026-09-11 · Sale · Disposed 10,712 · Balance 769,288 F4: Reflects weighted-average sale price (per share prices actually received ranged from $84.18 to $84.99). Upon appropriate request, the reporting person will provide information regarding the number of shares sold at each price within the range. |
| Ordinary SharesSEC Table I · non-derivative | IndirectBy Second Delaware 2003, LLC | 764,179 |
Reported balance
After 2026-09-11 transaction · row 5
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 5 · 2026-09-11 · Sale · Disposed 5,109 · Balance 764,179 F5: Reflects weighted-average sale price (per share prices actually received ranged from $85.00 to $85.99). Upon appropriate request, the reporting person will provide information regarding the number of shares sold at each price within the range. |
| Ordinary SharesSEC Table I · non-derivative | IndirectBy Second Delaware 2003, LLC | 764,000 |
Reported balance
After 2026-09-11 transaction · row 6
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 6 · 2026-09-11 · Sale · Disposed 179 · Balance 764,000 F6: Reflects weighted-average sale price (per share prices actually received ranged from $86.01 to $86.06). Upon appropriate request, the reporting person will provide information regarding the number of shares sold at each price within the range. |
| Ordinary SharesSEC Table I · non-derivative | IndirectBy RHS Delaware Holdings LLC | 28,375 |
Reported balance
Holding disclosure · report date 2026-09-11 · row 7
Holding and transaction disclosures are not merged.
1 source rowRow 7 · Balance 28,375 |
| Ordinary SharesSEC Table I · non-derivative | IndirectBy Eastern Irrevocable, LLC | 43,128 |
Reported balance
Holding disclosure · report date 2026-09-11 · row 8
Holding and transaction disclosures are not merged.
1 source rowRow 8 · Balance 43,128 F7: Includes 28,375 shares held by RHS Delaware Holdings LLC, of which Eastern Irrevocable, LLC and Western Irrevocable, LLC are the sole owners. |
| Ordinary SharesSEC Table I · non-derivative | IndirectBy Western Irrevocable, LLC | 47,088 |
Reported balance
Holding disclosure · report date 2026-09-11 · row 9
Holding and transaction disclosures are not merged.
1 source rowRow 9 · Balance 47,088 F7: Includes 28,375 shares held by RHS Delaware Holdings LLC, of which Eastern Irrevocable, LLC and Western Irrevocable, LLC are the sole owners. |
| Ordinary SharesSEC Table I · non-derivative | IndirectBy Delaware 2001 Investment Trust | 51,900 |
Reported balance
Holding disclosure · report date 2026-09-11 · row 10
Holding and transaction disclosures are not merged.
1 source rowRow 10 · Balance 51,900 |
| Ordinary SharesSEC Table I · non-derivative | IndirectBy Third Delaware 2011, LLC | 986,785 |
Reported balance
Holding disclosure · report date 2026-09-11 · row 11
Holding and transaction disclosures are not merged.
1 source rowRow 11 · Balance 986,785 |
Filing footnotes · ownership attribution and instrument terms
F1: Reflects weighted-average sale price (per share prices actually received ranged from $84.17 to $84.99). Upon appropriate request, the reporting person will provide information regarding the number of shares sold at each price within the range.
F2: Reflects weighted-average sale price (per share prices actually received ranged from $85.00 to $85.96). Upon appropriate request, the reporting person will provide information regarding the number of shares sold at each price within the range.
F3: Reflects weighted-average sale price (per share prices actually received ranged from $86.04 to $86.22). Upon appropriate request, the reporting person will provide information regarding the number of shares sold at each price within the range.
F4: Reflects weighted-average sale price (per share prices actually received ranged from $84.18 to $84.99). Upon appropriate request, the reporting person will provide information regarding the number of shares sold at each price within the range.
F5: Reflects weighted-average sale price (per share prices actually received ranged from $85.00 to $85.99). Upon appropriate request, the reporting person will provide information regarding the number of shares sold at each price within the range.
F6: Reflects weighted-average sale price (per share prices actually received ranged from $86.01 to $86.06). Upon appropriate request, the reporting person will provide information regarding the number of shares sold at each price within the range.
F7: Includes 28,375 shares held by RHS Delaware Holdings LLC, of which Eastern Irrevocable, LLC and Western Irrevocable, LLC are the sole owners.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 15, 2021 Filed Feb 16, 2021 17:58 UTC | CIMPRESS plc CMPR · Entity 4457 | GrantPerformance Share Units · Derivative | 58,668 | $0.00 Strike: $108.31 | $0.00 |
DisclosureSEC source: 0001262976-21-000012 · wf-form4_161349830337557.xml · derivative · entry 1 Keane Robert S · CIK 0001337084 · Director · CEO, Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,668 Underlying: Ordinary Shares · 58,668 shares Expires 2031-02-15 F1 · security: Each of these performance share units (PSU) represents a right to receive between 0 and 2.5 Cimpress ordinary shares upon the satisfaction of both (A) service-based vesting and (B) performance conditions relating to the compound annual growth rate (CAGR) of the three-year moving average daily price per share of Cimpress' ordinary shares (3YMA). The service-based vesting condition is that 25% of the original number of PSUs vest on each June 30 of 2021 through 2024 so long as the reporting person continues to be an eligible participant under Cimpress' 2020 Equity Incentive Plan on such vesting date. If the 3YMA CAGR equals or exceeds 11% on any of the sixth through tenth anniversaries of the grant date, then the reporting person is entitled to receive a distribution of up to 2.5 Cimpress ordinary shares for each vested PSU on a sliding scale based on the actual CAGR performance. F2 · derivative.exercise_price: This dollar amount is the 3YMA on the date of grant, which is the baseline against which the CAGR of the 3YMA will be measured. F1 · derivative.exercise_date: Each of these performance share units (PSU) represents a right to receive between 0 and 2.5 Cimpress ordinary shares upon the satisfaction of both (A) service-based vesting and (B) performance conditions relating to the compound annual growth rate (CAGR) of the three-year moving average daily price per share of Cimpress' ordinary shares (3YMA). The service-based vesting condition is that 25% of the original number of PSUs vest on each June 30 of 2021 through 2024 so long as the reporting person continues to be an eligible participant under Cimpress' 2020 Equity Incentive Plan on such vesting date. If the 3YMA CAGR equals or exceeds 11% on any of the sixth through tenth anniversaries of the grant date, then the reporting person is entitled to receive a distribution of up to 2.5 Cimpress ordinary shares for each vested PSU on a sliding scale based on the actual CAGR performance. Read SEC document |
| November 15, 2020 Filed Nov 17, 2020 14:11 UTC | CIMPRESS plc CMPR · Entity 4457 | GrantPerformance Share Units · Derivative | 1,123 | $0.00 Strike: $111.23 | $0.00 |
DisclosureSEC source: 0001262976-20-000097 · wf-form4_160562225766574.xml · derivative · entry 1 Keane Robert S · CIK 0001337084 · Director · CEO, Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,123 Underlying: Ordinary Shares · 1,123 shares Expires 2030-11-15 F1 · security: Each of these performance share units (PSU) represents a right to receive between 0 and 2.5 Cimpress ordinary shares upon the satisfaction of both (A) service-based vesting and (B) performance conditions relating to the compound annual growth rate (CAGR) of the three-year moving average daily price per share of Cimpress' ordinary shares (3YMA). The service-based vesting condition is that 25% of the original number of PSUs vest on each November 24 of 2021 through 2024 so long as the reporting person continues to be an eligible participant under Cimpress' 2016 Performance Incentive Plan on such vesting date. If the 3YMA CAGR equals or exceeds 11% on any of the sixth through tenth anniversaries of the grant date, then the reporting person is entitled to receive a distribution of up to 2.5 Cimpress ordinary shares for each vested PSU on a sliding scale based on the actual CAGR performance. F2 · derivative.exercise_price: This dollar amount is the 3YMA on the date of grant, which is the baseline against which the CAGR of the 3YMA will be measured. F1 · derivative.exercise_date: Each of these performance share units (PSU) represents a right to receive between 0 and 2.5 Cimpress ordinary shares upon the satisfaction of both (A) service-based vesting and (B) performance conditions relating to the compound annual growth rate (CAGR) of the three-year moving average daily price per share of Cimpress' ordinary shares (3YMA). The service-based vesting condition is that 25% of the original number of PSUs vest on each November 24 of 2021 through 2024 so long as the reporting person continues to be an eligible participant under Cimpress' 2016 Performance Incentive Plan on such vesting date. If the 3YMA CAGR equals or exceeds 11% on any of the sixth through tenth anniversaries of the grant date, then the reporting person is entitled to receive a distribution of up to 2.5 Cimpress ordinary shares for each vested PSU on a sliding scale based on the actual CAGR performance. Read SEC document |
| August 28, 2020 Filed Aug 31, 2020 20:11 UTC | ASTRONICS CORP ATRO · Entity 4200 | Exercise / conversionRestricted Stock Unit · Derivative | 5,600 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-048751 · doc4.xml · derivative · entry 8 Keane Robert S · CIK 0001337084 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: $.01 PV Common Stock · 5,600 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each restricted stock unit represents the right to receive, at settlement, one share of common stock. F5 · derivative.exercise_date: These restricted stock units granted on August 28, 2020. F5 · derivative.expiration_date: These restricted stock units granted on August 28, 2020. Read SEC document |
| August 28, 2020 Filed Aug 31, 2020 20:11 UTC | ASTRONICS CORP ATRO · Entity 4200 | Exercise / conversion$0.01 PV Common Stock | 5,600 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-048751 · doc4.xml · nonDerivative · entry 1 Keane Robert S · CIK 0001337084 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,600 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 21, 2020 Filed Aug 25, 2020 20:44 UTC | ASTRONICS CORP ATRO · Entity 4200 | Other$0.01 PV Class B Stock | 373,827 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-048244 · doc4.xml · nonDerivative · entry 5 Keane Robert S · CIK 0001337084 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Note Disclosed balance after: 448,199 F3 · price: As a result of estate planning transactions, 5096 Saranac LLC made an in-kind distribution of the 85,695 shares of Common Stock and 1,409,614 shares of Class B Common Stock held by it to its members, including 373,827 shares of Class B Common Stock to Boston & Saranac. The other shares were distributed in-kind to the Sibling Trusts. F3 · ownership.nature: As a result of estate planning transactions, 5096 Saranac LLC made an in-kind distribution of the 85,695 shares of Common Stock and 1,409,614 shares of Class B Common Stock held by it to its members, including 373,827 shares of Class B Common Stock to Boston & Saranac. The other shares were distributed in-kind to the Sibling Trusts. F4 · ownership.nature: The direct owner is Boston & Saranac LLC. Read SEC document |
| August 21, 2020 Filed Aug 25, 2020 20:44 UTC | ASTRONICS CORP ATRO · Entity 4200 | Other$0.01 PV Class B Stock | 1,409,614 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-048244 · doc4.xml · nonDerivative · entry 4 Keane Robert S · CIK 0001337084 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Note Disclosed balance after: 0 F3 · price: As a result of estate planning transactions, 5096 Saranac LLC made an in-kind distribution of the 85,695 shares of Common Stock and 1,409,614 shares of Class B Common Stock held by it to its members, including 373,827 shares of Class B Common Stock to Boston & Saranac. The other shares were distributed in-kind to the Sibling Trusts. F2 · ownership.nature: The direct owner is 5096 Saranac LLC, a Delaware limited liability company which was established by a trust of the Reporting Persons father, Kevin T. Keane. As a result of estate planning transactions, the direct owner is now owned 25% by Boston & Saranac LLC, a Delaware limited liability company("Boston & Saranac"), and 75% by limited liability companies owned by trusts for the benefit of the siblings or descendants of siblings of the Reporting Person ("Sibling Trusts"). Boston & Saranac is 100% owned by a trust whose beneficiaries are the Reporting Person and his spouse. F3 · ownership.nature: As a result of estate planning transactions, 5096 Saranac LLC made an in-kind distribution of the 85,695 shares of Common Stock and 1,409,614 shares of Class B Common Stock held by it to its members, including 373,827 shares of Class B Common Stock to Boston & Saranac. The other shares were distributed in-kind to the Sibling Trusts. Read SEC document |
| August 21, 2020 Filed Aug 25, 2020 20:44 UTC | ASTRONICS CORP ATRO · Entity 4200 | Conversion$0.01 PV Class B Stock | 85,695 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-048244 · doc4.xml · nonDerivative · entry 3 Keane Robert S · CIK 0001337084 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Note Disclosed balance after: 1,409,614 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each share of Class B Stock is convertible at any time, at the option of the holder, into one fully paid and non-assessable share of Common Stock. F2 · ownership.nature: The direct owner is 5096 Saranac LLC, a Delaware limited liability company which was established by a trust of the Reporting Persons father, Kevin T. Keane. As a result of estate planning transactions, the direct owner is now owned 25% by Boston & Saranac LLC, a Delaware limited liability company("Boston & Saranac"), and 75% by limited liability companies owned by trusts for the benefit of the siblings or descendants of siblings of the Reporting Person ("Sibling Trusts"). Boston & Saranac is 100% owned by a trust whose beneficiaries are the Reporting Person and his spouse. Read SEC document |
| August 21, 2020 Filed Aug 25, 2020 20:44 UTC | ASTRONICS CORP ATRO · Entity 4200 | Other$0.01 PV Common Stock | 85,695 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-048244 · doc4.xml · nonDerivative · entry 2 Keane Robert S · CIK 0001337084 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Note Disclosed balance after: 0 F3 · price: As a result of estate planning transactions, 5096 Saranac LLC made an in-kind distribution of the 85,695 shares of Common Stock and 1,409,614 shares of Class B Common Stock held by it to its members, including 373,827 shares of Class B Common Stock to Boston & Saranac. The other shares were distributed in-kind to the Sibling Trusts. F2 · ownership.nature: The direct owner is 5096 Saranac LLC, a Delaware limited liability company which was established by a trust of the Reporting Persons father, Kevin T. Keane. As a result of estate planning transactions, the direct owner is now owned 25% by Boston & Saranac LLC, a Delaware limited liability company("Boston & Saranac"), and 75% by limited liability companies owned by trusts for the benefit of the siblings or descendants of siblings of the Reporting Person ("Sibling Trusts"). Boston & Saranac is 100% owned by a trust whose beneficiaries are the Reporting Person and his spouse. F3 · ownership.nature: As a result of estate planning transactions, 5096 Saranac LLC made an in-kind distribution of the 85,695 shares of Common Stock and 1,409,614 shares of Class B Common Stock held by it to its members, including 373,827 shares of Class B Common Stock to Boston & Saranac. The other shares were distributed in-kind to the Sibling Trusts. Read SEC document |
| August 21, 2020 Filed Aug 25, 2020 20:44 UTC | ASTRONICS CORP ATRO · Entity 4200 | Conversion$0.01 PV Common Stock | 85,695 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-048244 · doc4.xml · nonDerivative · entry 1 Keane Robert S · CIK 0001337084 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Note Disclosed balance after: 85,695 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each share of Class B Stock is convertible at any time, at the option of the holder, into one fully paid and non-assessable share of Common Stock. F2 · ownership.nature: The direct owner is 5096 Saranac LLC, a Delaware limited liability company which was established by a trust of the Reporting Persons father, Kevin T. Keane. As a result of estate planning transactions, the direct owner is now owned 25% by Boston & Saranac LLC, a Delaware limited liability company("Boston & Saranac"), and 75% by limited liability companies owned by trusts for the benefit of the siblings or descendants of siblings of the Reporting Person ("Sibling Trusts"). Boston & Saranac is 100% owned by a trust whose beneficiaries are the Reporting Person and his spouse. Read SEC document |
| August 15, 2020 Filed Aug 18, 2020 00:49 UTC | CIMPRESS plc CMPR · Entity 4457 | GrantPerformance Share Unit · Derivative | 887 | $0.00 Strike: $112.72 | $0.00 |
DisclosureSEC source: 0001262976-20-000061 · wf-form4_159771175137264.xml · derivative · entry 2 Keane Robert S · CIK 0001337084 · Director · CEO, Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 887 Underlying: Ordinary Shares · 887 shares Expires 2030-08-15 F1 · derivative.exercise_price: This dollar amount is the three-year moving average of Cimpress' share price (3YMA) on the date of grant, which is the baseline against which the compound annual growth rate (CAGR) of the 3YMA will be measured. F2 · derivative.exercise_date: Each performance share unit (PSU) represents a right to receive between 0 and 2.5 Cimpress ordinary shares upon the satisfaction of both (A) service-based vesting and (B) performance conditions relating to the CAGR of the 3YMA. The service-based vesting condition is that 25% of the PSUs vest on each of September 30, 2020, December 31, 2020, March 31, 2021, and June 30, 2021 so long as the reporting person continues to be an eligible participant under Cimpress' 2016 Performance Incentive Plan on the vesting date. If the 3YMA CAGR equals or exceeds 11% on any of the sixth through tenth anniversaries of the grant date then the reporting person is entitled to receive a distribution of up to 2.5 Cimpress ordinary shares for each vested PSU on a sliding scale based on the actual CAGR performance. Read SEC document |
| August 15, 2020 Filed Aug 18, 2020 00:49 UTC | CIMPRESS plc CMPR · Entity 4457 | GrantPerformance Share Units · Derivative | 14,322 | $0.00 Strike: $112.72 | $0.00 |
DisclosureSEC source: 0001262976-20-000061 · wf-form4_159771175137264.xml · derivative · entry 1 Keane Robert S · CIK 0001337084 · Director · CEO, Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,322 Underlying: Ordinary Shares · 14,322 shares Expires 2030-08-15 F1 · derivative.exercise_price: This dollar amount is the three-year moving average of Cimpress' share price (3YMA) on the date of grant, which is the baseline against which the compound annual growth rate (CAGR) of the 3YMA will be measured. F2 · derivative.exercise_date: Each performance share unit (PSU) represents a right to receive between 0 and 2.5 Cimpress ordinary shares upon the satisfaction of both (A) service-based vesting and (B) performance conditions relating to the CAGR of the 3YMA. The service-based vesting condition is that 25% of the PSUs vest on each of September 30, 2020, December 31, 2020, March 31, 2021, and June 30, 2021 so long as the reporting person continues to be an eligible participant under Cimpress' 2016 Performance Incentive Plan on the vesting date. If the 3YMA CAGR equals or exceeds 11% on any of the sixth through tenth anniversaries of the grant date then the reporting person is entitled to receive a distribution of up to 2.5 Cimpress ordinary shares for each vested PSU on a sliding scale based on the actual CAGR performance. Read SEC document |
| June 05, 2020 Filed Jun 10, 2020 00:01 UTC Amendment | ASTRONICS CORP ATRO · Entity 4200 | Other$0.01 PV Class B Stock | 74,372 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-035415 · doc4a.xml · nonDerivative · entry 4 Keane Robert S · CIK 0001337084 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Note (2) Disclosed balance after: 74,372 F2 · ownership.nature: The direct owner is Boston & Saranac. Read SEC document |
| June 05, 2020 Filed Jun 10, 2020 00:01 UTC Amendment | ASTRONICS CORP ATRO · Entity 4200 | Other$0.01 PV Class B Stock | 297,488 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-035415 · doc4a.xml · nonDerivative · entry 3 Keane Robert S · CIK 0001337084 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Note (3) Disclosed balance after: 0 F3 · ownership.nature: As a result of the same estate planning transaction in Note 1 above, 223,116 shares of Class B Stock have been transferred to entities 100% owned by trusts whose beneficiaries are the siblings or the descendants of siblings of the Reporting Person ("Sibling Trusts"). 74,372 shares of Class B Stock have been transferred to Boston & Saranac. Read SEC document |
| June 05, 2020 Filed Jun 10, 2020 00:01 UTC Amendment | ASTRONICS CORP ATRO · Entity 4200 | Other$0.01 PV Common Stock | 44,726 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-035415 · doc4a.xml · nonDerivative · entry 2 Keane Robert S · CIK 0001337084 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Note (2) Disclosed balance after: 44,726 F2 · ownership.nature: The direct owner is Boston & Saranac. Read SEC document |
| June 05, 2020 Filed Jun 10, 2020 00:01 UTC Amendment | ASTRONICS CORP ATRO · Entity 4200 | Other$0.01 PV Common Stock | 178,904 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-035415 · doc4a.xml · nonDerivative · entry 1 Keane Robert S · CIK 0001337084 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Note (1) Disclosed balance after: 2,222 F1 · ownership.nature: The direct owner is the Estate of Kevin T. Keane. The Reporting Person is one of multiple beneficiaries to a trust to be established by that estate. The entire amount of the estate's interest is reported on this form, however the Reporting Person's proportionate interest is below 25%. Shares held by the estate have been transferred to entities beneficially owned by descendants of Kevin T. Keane in an estate planning transactions. As a result, 134,178 Shares of Common Stock have been transferred to entities of which certain of the Reporting Persons's siblings are the primary beneficiary trusts. 44,726 shares of Common Stock have been transferred to Boston & Saranac LLC, a Delaware limited liability company 100% owned by a trust whose beneficiaries are the Reporting Person and his Spouse ("Boston & Saranac"). Read SEC document |
| June 05, 2020 Filed Jun 9, 2020 20:30 UTC | ASTRONICS CORP ATRO · Entity 4200 | Other$0.01 PV Class B Stock | 74,372 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-035263 · doc4.xml · nonDerivative · entry 4 Keane Robert S · CIK 0001337084 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Note (2) Disclosed balance after: 74,372 F2 · ownership.nature: The direct owner is Boston & Saranac LLC, of which the Reporting Person and his spouse are the primary beneficiary trusts. Read SEC document |
| June 05, 2020 Filed Jun 9, 2020 20:30 UTC | ASTRONICS CORP ATRO · Entity 4200 | Other$0.01 PV Class B Stock | 297,488 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-035263 · doc4.xml · nonDerivative · entry 3 Keane Robert S · CIK 0001337084 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Note (3) & (4) Disclosed balance after: 1,495,340 F3 · ownership.nature: The direct owner is 5096 Saranac LLC, of which the Estate of Kevin T. Keane, the estate of the deceased father of this form's Reporting Person, was formerly the direct owner. The Reporting Person is one of multiple beneficiaries (and one of multiple trustees) to a trust to be established by that estate. The entire amount of the estate's interest is reported on this form, however the Reporting Person's proportionate interest is below 25%. F4 · ownership.nature: 25% of the ownership of 5096 Saranac LLC has been transferred to Boston & Saranac LLC, of which the Reporting Person and his spouse are the primary beneficiary trusts, and the remaining 75% ownership of 5096 Saranac LLC has been transferred to entities of which certain other of the Reporting Person's siblings are the primary beneficiary trusts. 223,116 shares of Class B Stock have been transferred to entities of which certain of the Reporting Person's siblings are the primary beneficiary trusts. 74,372 shares of Class B Common Stock have been transferred to Boston & Saranac LLC, of which the Reporting Person and his spouse are the primary beneficiary trusts. Read SEC document |
| June 05, 2020 Filed Jun 9, 2020 20:30 UTC | ASTRONICS CORP ATRO · Entity 4200 | Other$0.01 PV Common Stock | 44,726 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-035263 · doc4.xml · nonDerivative · entry 2 Keane Robert S · CIK 0001337084 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Note (2) Disclosed balance after: 44,726 F2 · ownership.nature: The direct owner is Boston & Saranac LLC, of which the Reporting Person and his spouse are the primary beneficiary trusts. Read SEC document |
| June 05, 2020 Filed Jun 9, 2020 20:30 UTC | ASTRONICS CORP ATRO · Entity 4200 | Other$0.01 PV Common Stock | 178,904 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-035263 · doc4.xml · nonDerivative · entry 1 Keane Robert S · CIK 0001337084 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Note (1) Disclosed balance after: 2,222 F1 · ownership.nature: The direct owner is the Estate of Kevin T. Keane, the father of this form's Reporting Person. The Reporting Person is one of multiple beneficiaries (and one of multiple trustees) to a trust to be established by that estate. The entire amount of the estate's interest is reported on this form, however the Reporting Person's proportionate interest is below 25%. 134,178 Shares of Common Stock have been transferred to entities of which certain of the Reporting Persons's siblings are the primary beneficiary trusts. 44,726 shares of Common Stock have been transferred to Boston & Saranac LLC, of which the Reporting Person and his spouse are the primary beneficiary trusts. Read SEC document |
| February 28, 2020 Filed Mar 2, 2020 21:46 UTC | ASTRONICS CORP ATRO · Entity 4200 | GrantRestricted Stock Unit · Derivative | 5,600 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-014522 · doc4.xml · derivative · entry 15 Keane Robert S · CIK 0001337084 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,600 Underlying: $.01 PV Common Stock · 5,600 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit represents the right to receive, at settlement, one share of common stock. F4 · derivative.exercise_date: These restricted stock units are scheduled to vest 100% on August 28, 2020. F4 · derivative.expiration_date: These restricted stock units are scheduled to vest 100% on August 28, 2020. Read SEC document |
| February 26, 2020 Filed Feb 28, 2020 16:23 UTC | CIMPRESS plc CMPR · Entity 4457 | Exercise / conversionOption (right to buy) · Derivative | 112,231 | $50.00 Strike: $50.00 | $5,611,550.00 |
DisclosureSEC source: 0001262976-20-000023 · wf-form4_158290700131582.xml · derivative · entry 20 Keane Robert S · CIK 0001337084 · Director · CEO, Chairman 10b5-1 filing: Not disclosed Ownership: Indirect · By Western Irrevocable, LLC Disclosed balance after: 0 Underlying: Ordinary Shares · 112,231 shares Expires 2020-05-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: The option exercise price per share is $50.00, which is at least 33% higher than the closing price of Cimpress' ordinary shares on the NASDAQ Global Select Market on the date of grant. F7 · derivative.exercise_price: $0.0001 added to exercise price solely to differentiate the securities on this Form 4. F5 · derivative.exercise_date: The share options vest over a seven-year period as follows: 6.25% of the original number of ordinary shares subject to the share options vest on the Exercisable Date in Table II. The remaining ordinary shares vest on a quarterly basis over the subsequent six years in tranches ranging from 1.56% to 10.94% of the original number of ordinary shares subject to the option. F6 · derivative.exercise_date: In addition to the vesting restrictions referred to in footnote 5 above, these share options are exercisable only on days when the high price per share of Cimpress' ordinary shares on NASDAQ equals or exceeds $75.00. Read SEC document |
| February 26, 2020 Filed Feb 28, 2020 16:23 UTC | CIMPRESS plc CMPR · Entity 4457 | Exercise / conversionOption (right to buy) · Derivative | 500,000 | $50.00 Strike: $50.00 | $25,000,000.00 |
DisclosureSEC source: 0001262976-20-000023 · wf-form4_158290700131582.xml · derivative · entry 19 Keane Robert S · CIK 0001337084 · Director · CEO, Chairman 10b5-1 filing: Not disclosed Ownership: Indirect · By Western Irrevocable, LLC Disclosed balance after: 0 Underlying: Ordinary Shares · 500,000 shares Expires 2020-05-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: The option exercise price per share is $50.00, which is at least 33% higher than the closing price of Cimpress' ordinary shares on the NASDAQ Global Select Market on the date of grant. F5 · derivative.exercise_date: The share options vest over a seven-year period as follows: 6.25% of the original number of ordinary shares subject to the share options vest on the Exercisable Date in Table II. The remaining ordinary shares vest on a quarterly basis over the subsequent six years in tranches ranging from 1.56% to 10.94% of the original number of ordinary shares subject to the option. F6 · derivative.exercise_date: In addition to the vesting restrictions referred to in footnote 5 above, these share options are exercisable only on days when the high price per share of Cimpress' ordinary shares on NASDAQ equals or exceeds $75.00. Read SEC document |
| February 26, 2020 Filed Feb 28, 2020 16:23 UTC | CIMPRESS plc CMPR · Entity 4457 | Exercise / conversionOption (right to buy) · Derivative | 48,400 | $47.91 Strike: $47.91 | $2,318,844.00 |
DisclosureSEC source: 0001262976-20-000023 · wf-form4_158290700131582.xml · derivative · entry 18 Keane Robert S · CIK 0001337084 · Director · CEO, Chairman 10b5-1 filing: Not disclosed Ownership: Indirect · By Western Irrevocable, LLC Disclosed balance after: 0 Underlying: Ordinary Shares · 48,400 shares Expires 2020-05-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option became exercisable as to 25% of the original number of shares on the Exercisable Date shown on Table II, and as to an additional 6.25% of the original number of shares at the end of each successive three-month period thereafter. Read SEC document |
| February 26, 2020 Filed Feb 28, 2020 16:23 UTC | CIMPRESS plc CMPR · Entity 4457 | Exercise / conversionOption (right to buy) · Derivative | 500,000 | $50.00 Strike: $50.00 | $25,000,000.00 |
DisclosureSEC source: 0001262976-20-000023 · wf-form4_158290700131582.xml · derivative · entry 17 Keane Robert S · CIK 0001337084 · Director · CEO, Chairman 10b5-1 filing: Not disclosed Ownership: Indirect · By The Eastern Irrevocable, LLC Disclosed balance after: 0 Underlying: Ordinary Shares · 500,000 shares Expires 2020-05-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: The option exercise price per share is $50.00, which is at least 33% higher than the closing price of Cimpress' ordinary shares on the NASDAQ Global Select Market on the date of grant. F7 · derivative.exercise_price: $0.0001 added to exercise price solely to differentiate the securities on this Form 4. F5 · derivative.exercise_date: The share options vest over a seven-year period as follows: 6.25% of the original number of ordinary shares subject to the share options vest on the Exercisable Date in Table II. The remaining ordinary shares vest on a quarterly basis over the subsequent six years in tranches ranging from 1.56% to 10.94% of the original number of ordinary shares subject to the option. F6 · derivative.exercise_date: In addition to the vesting restrictions referred to in footnote 5 above, these share options are exercisable only on days when the high price per share of Cimpress' ordinary shares on NASDAQ equals or exceeds $75.00. Read SEC document |
| February 26, 2020 Filed Feb 28, 2020 16:23 UTC | CIMPRESS plc CMPR · Entity 4457 | Exercise / conversionOption (right to buy) · Derivative | 500,000 | $50.00 Strike: $50.00 | $25,000,000.00 |
DisclosureSEC source: 0001262976-20-000023 · wf-form4_158290700131582.xml · derivative · entry 16 Keane Robert S · CIK 0001337084 · Director · CEO, Chairman 10b5-1 filing: Not disclosed Ownership: Indirect · By The Eastern Irrevocable, LLC Disclosed balance after: 0 Underlying: Ordinary Shares · 500,000 shares Expires 2020-05-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: The option exercise price per share is $50.00, which is at least 33% higher than the closing price of Cimpress' ordinary shares on the NASDAQ Global Select Market on the date of grant. F5 · derivative.exercise_date: The share options vest over a seven-year period as follows: 6.25% of the original number of ordinary shares subject to the share options vest on the Exercisable Date in Table II. The remaining ordinary shares vest on a quarterly basis over the subsequent six years in tranches ranging from 1.56% to 10.94% of the original number of ordinary shares subject to the option. F6 · derivative.exercise_date: In addition to the vesting restrictions referred to in footnote 5 above, these share options are exercisable only on days when the high price per share of Cimpress' ordinary shares on NASDAQ equals or exceeds $75.00. Read SEC document |
| February 26, 2020 Filed Feb 28, 2020 16:23 UTC | CIMPRESS plc CMPR · Entity 4457 | Exercise / conversionOption (right to buy) · Derivative | 48,400 | $47.91 Strike: $47.91 | $2,318,844.00 |
DisclosureSEC source: 0001262976-20-000023 · wf-form4_158290700131582.xml · derivative · entry 15 Keane Robert S · CIK 0001337084 · Director · CEO, Chairman 10b5-1 filing: Not disclosed Ownership: Indirect · By The Eastern Irrevocable, LLC Disclosed balance after: 0 Underlying: Ordinary Shares · 48,400 shares Expires 2020-05-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option became exercisable as to 25% of the original number of shares on the Exercisable Date shown on Table II, and as to an additional 6.25% of the original number of shares at the end of each successive three-month period thereafter. Read SEC document |
| February 26, 2020 Filed Feb 28, 2020 16:23 UTC | CIMPRESS plc CMPR · Entity 4457 | Tax withholdingOrdinary Shares | 445,220 | $119.91 | $53,386,330.20 |
DisclosureSEC source: 0001262976-20-000023 · wf-form4_158290700131582.xml · nonDerivative · entry 8 Keane Robert S · CIK 0001337084 · Director · CEO, Chairman 10b5-1 filing: Not disclosed Ownership: Indirect · By Western Irrevocable, LLC Disclosed balance after: 573,935 F2 · shares: Of the 445,220 shares forfeited, 274,626 shares were forfeited as payment of the exercise price and 170,594 shares were forfeited as payment of the withholding taxes. F1 · balance_after: Includes 28,375 shares held by RHS Holdings Incorporated, of which The Eastern Irrevocable Trust and The Western Irrevocable Trust are the sole shareholders. Read SEC document |
| February 26, 2020 Filed Feb 28, 2020 16:23 UTC | CIMPRESS plc CMPR · Entity 4457 | Exercise / conversionOrdinary Shares | 112,231 | $50.00 | $5,611,550.00 |
DisclosureSEC source: 0001262976-20-000023 · wf-form4_158290700131582.xml · nonDerivative · entry 7 Keane Robert S · CIK 0001337084 · Director · CEO, Chairman 10b5-1 filing: Not disclosed Ownership: Indirect · By Western Irrevocable, LLC Disclosed balance after: 1,019,155 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 28,375 shares held by RHS Holdings Incorporated, of which The Eastern Irrevocable Trust and The Western Irrevocable Trust are the sole shareholders. Read SEC document |
| February 26, 2020 Filed Feb 28, 2020 16:23 UTC | CIMPRESS plc CMPR · Entity 4457 | Exercise / conversionOrdinary Shares | 500,000 | $50.00 | $25,000,000.00 |
DisclosureSEC source: 0001262976-20-000023 · wf-form4_158290700131582.xml · nonDerivative · entry 6 Keane Robert S · CIK 0001337084 · Director · CEO, Chairman 10b5-1 filing: Not disclosed Ownership: Indirect · By Western Irrevocable, LLC Disclosed balance after: 906,924 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 28,375 shares held by RHS Holdings Incorporated, of which The Eastern Irrevocable Trust and The Western Irrevocable Trust are the sole shareholders. Read SEC document |
| February 26, 2020 Filed Feb 28, 2020 16:23 UTC | CIMPRESS plc CMPR · Entity 4457 | Exercise / conversionOrdinary Shares | 48,400 | $47.91 | $2,318,844.00 |
DisclosureSEC source: 0001262976-20-000023 · wf-form4_158290700131582.xml · nonDerivative · entry 5 Keane Robert S · CIK 0001337084 · Director · CEO, Chairman 10b5-1 filing: Not disclosed Ownership: Indirect · By Western Irrevocable, LLC Disclosed balance after: 406,924 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 28,375 shares held by RHS Holdings Incorporated, of which The Eastern Irrevocable Trust and The Western Irrevocable Trust are the sole shareholders. Read SEC document |
| February 26, 2020 Filed Feb 28, 2020 16:23 UTC | CIMPRESS plc CMPR · Entity 4457 | Tax withholdingOrdinary Shares | 445,220 | $119.91 | $53,386,330.20 |
DisclosureSEC source: 0001262976-20-000023 · wf-form4_158290700131582.xml · nonDerivative · entry 4 Keane Robert S · CIK 0001337084 · Director · CEO, Chairman 10b5-1 filing: Not disclosed Ownership: Indirect · By Eastern Irrevocable, LLC Disclosed balance after: 573,975 F2 · shares: Of the 445,220 shares forfeited, 274,626 shares were forfeited as payment of the exercise price and 170,594 shares were forfeited as payment of the withholding taxes. F1 · balance_after: Includes 28,375 shares held by RHS Holdings Incorporated, of which The Eastern Irrevocable Trust and The Western Irrevocable Trust are the sole shareholders. Read SEC document |
| February 26, 2020 Filed Feb 28, 2020 16:23 UTC | CIMPRESS plc CMPR · Entity 4457 | Exercise / conversionOrdinary Shares | 112,231 | $50.00 | $5,611,550.00 |
DisclosureSEC source: 0001262976-20-000023 · wf-form4_158290700131582.xml · nonDerivative · entry 3 Keane Robert S · CIK 0001337084 · Director · CEO, Chairman 10b5-1 filing: Not disclosed Ownership: Indirect · By Eastern Irrevocable, LLC Disclosed balance after: 1,019,195 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 28,375 shares held by RHS Holdings Incorporated, of which The Eastern Irrevocable Trust and The Western Irrevocable Trust are the sole shareholders. Read SEC document |
| February 26, 2020 Filed Feb 28, 2020 16:23 UTC | CIMPRESS plc CMPR · Entity 4457 | Exercise / conversionOrdinary Shares | 500,000 | $50.00 | $25,000,000.00 |
DisclosureSEC source: 0001262976-20-000023 · wf-form4_158290700131582.xml · nonDerivative · entry 2 Keane Robert S · CIK 0001337084 · Director · CEO, Chairman 10b5-1 filing: Not disclosed Ownership: Indirect · By Eastern Irrevocable, LLC Disclosed balance after: 906,964 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 28,375 shares held by RHS Holdings Incorporated, of which The Eastern Irrevocable Trust and The Western Irrevocable Trust are the sole shareholders. Read SEC document |
| February 26, 2020 Filed Feb 28, 2020 16:23 UTC | CIMPRESS plc CMPR · Entity 4457 | Exercise / conversionOrdinary Shares | 48,400 | $47.91 | $2,318,844.00 |
DisclosureSEC source: 0001262976-20-000023 · wf-form4_158290700131582.xml · nonDerivative · entry 1 Keane Robert S · CIK 0001337084 · Director · CEO, Chairman 10b5-1 filing: Not disclosed Ownership: Indirect · By Eastern Irrevocable, LLC Disclosed balance after: 406,964 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 28,375 shares held by RHS Holdings Incorporated, of which The Eastern Irrevocable Trust and The Western Irrevocable Trust are the sole shareholders. Read SEC document |
| November 15, 2019 Filed Nov 19, 2019 16:43 UTC | CIMPRESS plc CMPR · Entity 4457 | GrantPerformance Share Units · Derivative | 1,119 | $0.00 Strike: $111.70 | $0.00 |
DisclosureSEC source: 0001262976-19-000108 · wf-form4_157418182452292.xml · derivative · entry 1 Keane Robert S · CIK 0001337084 · Director · CEO, Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,119 Underlying: Ordinary Shares · 1,119 shares Expires 2029-11-21 F1 · derivative.exercise_price: This dollar amount is the three-year moving average of the daily closing share price of Cimpress' ordinary shares (3YMA) on the date of grant, which is the baseline against which the compound annual growth rate (CAGR) of the 3YMA will be measured. F2 · derivative.exercise_date: Each of these performance share units (PSU) represents a right to receive between 0 and 2.5 Cimpress ordinary shares upon the satisfaction of both (A) service-based vesting and (B) performance conditions relating to the CAGR of the 3YMA. The service-based vesting condition is that 25% of the original number of PSUs vest on each November 21 of 2020 through 2023 so long as the reporting person continues to be an eligible participant under Cimpress' 2016 Performance Incentive Plan on such vesting date. If the 3YMA CAGR equals or exceeds 11% on any of the sixth through tenth anniversaries of the grant date, then the reporting person is entitled to receive a distribution of up to 2.5 Cimpress ordinary shares for each vested PSU on a sliding scale based on the actual CAGR performance. Read SEC document |
| August 15, 2019 Filed Aug 19, 2019 20:44 UTC | CIMPRESS plc CMPR · Entity 4457 | GrantPerformance Share Unit_ · Derivative | 918 | $0.00 Strike: $108.92 | $0.00 |
DisclosureSEC source: 0001262976-19-000076 · wf-form4_156624743877483.xml · derivative · entry 3 Keane Robert S · CIK 0001337084 · Director · CEO, Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 918 Underlying: Ordinary Shares · 918 shares Expires 2029-08-15 F1 · derivative.exercise_price: This dollar amount is the three-year moving average (3YMA) on the date of grant, which is the baseline against which the compound annual growth rate (CAGR) of the 3YMA will be measured. F3 · derivative.exercise_date: Each performance share unit (PSU) represents a right to receive between 0 and 2.5 Cimpress ordinary shares upon the satisfaction of both (A) service-based vesting and (B) performance conditions relating to the CAGR of the 3YMA. The service-based vesting condition is that 25% of the original number of PSUs vest on each of September 30, 2019, December 31, 2019, March 31, 2020, and June 30, 2020 so long as the reporting person continues to be an eligible participant under Cimpress' 2016 Performance Incentive Plan on the vesting date. If the 3YMA CAGR equals or exceeds 11% on any of the sixth through tenth anniversaries of the grant date then the reporting person is entitled to receive a distribution of up to 2.5 Cimpress ordinary shares for each vested PSU on a sliding scale based on the actual CAGR performance. Read SEC document |
| August 15, 2019 Filed Aug 19, 2019 20:44 UTC | CIMPRESS plc CMPR · Entity 4457 | GrantPerformance Share Unit · Derivative | 14,931 | $0.00 Strike: $108.92 | $0.00 |
DisclosureSEC source: 0001262976-19-000076 · wf-form4_156624743877483.xml · derivative · entry 2 Keane Robert S · CIK 0001337084 · Director · CEO, Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,931 Underlying: Ordinary Shares · 14,931 shares Expires 2029-08-15 F1 · derivative.exercise_price: This dollar amount is the three-year moving average (3YMA) on the date of grant, which is the baseline against which the compound annual growth rate (CAGR) of the 3YMA will be measured. F3 · derivative.exercise_date: Each performance share unit (PSU) represents a right to receive between 0 and 2.5 Cimpress ordinary shares upon the satisfaction of both (A) service-based vesting and (B) performance conditions relating to the CAGR of the 3YMA. The service-based vesting condition is that 25% of the original number of PSUs vest on each of September 30, 2019, December 31, 2019, March 31, 2020, and June 30, 2020 so long as the reporting person continues to be an eligible participant under Cimpress' 2016 Performance Incentive Plan on the vesting date. If the 3YMA CAGR equals or exceeds 11% on any of the sixth through tenth anniversaries of the grant date then the reporting person is entitled to receive a distribution of up to 2.5 Cimpress ordinary shares for each vested PSU on a sliding scale based on the actual CAGR performance. Read SEC document |
| August 15, 2019 Filed Aug 19, 2019 20:44 UTC | CIMPRESS plc CMPR · Entity 4457 | GrantPerformance Share Units · Derivative | 57,381 | $0.00 Strike: $108.92 | $0.00 |
DisclosureSEC source: 0001262976-19-000076 · wf-form4_156624743877483.xml · derivative · entry 1 Keane Robert S · CIK 0001337084 · Director · CEO, Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,381 Underlying: Ordinary Shares · 57,381 shares Expires 2029-08-15 F1 · derivative.exercise_price: This dollar amount is the three-year moving average (3YMA) on the date of grant, which is the baseline against which the compound annual growth rate (CAGR) of the 3YMA will be measured. F2 · derivative.exercise_date: Each of these performance share units (PSU) represents a right to receive between 0 and 2.5 Cimpress ordinary shares upon the satisfaction of both (A) service-based vesting and (B) performance conditions relating to the CAGR of the 3YMA. The service-based vesting condition is that 25% of the original number of PSUs vest on each June 30 of 2020 through 2023 so long as the reporting person continues to be an eligible participant under Cimpress' 2016 Performance Incentive Plan on such vesting date. If the 3YMA CAGR equals or exceeds 11% on any of the sixth through tenth anniversaries of the grant date then the reporting person is entitled to receive a distribution of up to 2.5 Cimpress ordinary shares for each vested PSU on a sliding scale based on the actual CAGR performance. Read SEC document |
| May 03, 2019 Filed May 6, 2019 17:26 UTC | CIMPRESS plc CMPR · Entity 4457 | Exercise / conversionOption (right to buy) · Derivative | 73,014 | $0.00 Strike: $34.25 | $0.00 |
DisclosureSEC source: 0001262976-19-000034 · wf-form4_155716358610315.xml · derivative · entry 12 Keane Robert S · CIK 0001337084 · Director · CEO, Chairman 10b5-1 filing: Not disclosed Ownership: Indirect · By Western Irrevocable, LLC Disclosed balance after: 0 Underlying: Ordinary Shares · 73,014 shares Expires 2019-05-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person on November 27, 2018. F3 · derivative.exercise_date: This option became exercisable as to 25% of the original number of shares on the Exercisable Date shown on Table II, and as to an additional 6.25% of the original number of shares at the end of each successive three-month period thereafter. Read SEC document |
| May 03, 2019 Filed May 6, 2019 17:26 UTC | CIMPRESS plc CMPR · Entity 4457 | Exercise / conversionOption (right to buy) · Derivative | 73,014 | $0.00 Strike: $34.25 | $0.00 |
DisclosureSEC source: 0001262976-19-000034 · wf-form4_155716358610315.xml · derivative · entry 11 Keane Robert S · CIK 0001337084 · Director · CEO, Chairman 10b5-1 filing: Not disclosed Ownership: Indirect · By Eastern Irrevocable, LLC Disclosed balance after: 0 Underlying: Ordinary Shares · 73,014 shares Expires 2019-05-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person on November 27, 2018. F3 · derivative.exercise_date: This option became exercisable as to 25% of the original number of shares on the Exercisable Date shown on Table II, and as to an additional 6.25% of the original number of shares at the end of each successive three-month period thereafter. Read SEC document |
| May 03, 2019 Filed May 6, 2019 17:26 UTC | CIMPRESS plc CMPR · Entity 4457 | Tax withholdingOrdinary Shares | 47,220 | $89.07 | $4,205,885.40 |
DisclosureSEC source: 0001262976-19-000034 · wf-form4_155716358610315.xml · nonDerivative · entry 4 Keane Robert S · CIK 0001337084 · Director · CEO, Chairman 10b5-1 filing: Not disclosed Ownership: Indirect · By Western Irrevocable, LLC Disclosed balance after: 367,024 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person on November 27, 2018. F2 · balance_after: Includes 36,875 shares held by RHS Holdings Incorporated, of which Eastern Irrevocable, LLC and Western Irrevocable, LLC are the sole shareholders. Read SEC document |
| May 03, 2019 Filed May 6, 2019 17:26 UTC | CIMPRESS plc CMPR · Entity 4457 | Exercise / conversionOrdinary Shares | 73,014 | $34.25 | $2,500,729.50 |
DisclosureSEC source: 0001262976-19-000034 · wf-form4_155716358610315.xml · nonDerivative · entry 3 Keane Robert S · CIK 0001337084 · Director · CEO, Chairman 10b5-1 filing: Not disclosed Ownership: Indirect · By Western Irrevocable, LLC Disclosed balance after: 414,244 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person on November 27, 2018. F2 · balance_after: Includes 36,875 shares held by RHS Holdings Incorporated, of which Eastern Irrevocable, LLC and Western Irrevocable, LLC are the sole shareholders. Read SEC document |
| May 03, 2019 Filed May 6, 2019 17:26 UTC | CIMPRESS plc CMPR · Entity 4457 | Tax withholdingOrdinary Shares | 47,220 | $89.07 | $4,205,885.40 |
DisclosureSEC source: 0001262976-19-000034 · wf-form4_155716358610315.xml · nonDerivative · entry 2 Keane Robert S · CIK 0001337084 · Director · CEO, Chairman 10b5-1 filing: Not disclosed Ownership: Indirect · By Eastern Irrevocable, LLC Disclosed balance after: 367,064 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person on November 27, 2018. F2 · balance_after: Includes 36,875 shares held by RHS Holdings Incorporated, of which Eastern Irrevocable, LLC and Western Irrevocable, LLC are the sole shareholders. Read SEC document |
| May 03, 2019 Filed May 6, 2019 17:26 UTC | CIMPRESS plc CMPR · Entity 4457 | Exercise / conversionOrdinary Shares | 73,014 | $34.25 | $2,500,729.50 |
DisclosureSEC source: 0001262976-19-000034 · wf-form4_155716358610315.xml · nonDerivative · entry 1 Keane Robert S · CIK 0001337084 · Director · CEO, Chairman 10b5-1 filing: Not disclosed Ownership: Indirect · By Eastern Irrevocable, LLC Disclosed balance after: 414,284 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person on November 27, 2018. F2 · balance_after: Includes 36,875 shares held by RHS Holdings Incorporated, of which Eastern Irrevocable, LLC and Western Irrevocable, LLC are the sole shareholders. Read SEC document |
| February 15, 2019 Filed Feb 19, 2019 19:34 UTC | CIMPRESS plc CMPR · Entity 4457 | GrantPerformance Share Units · Derivative | 7,116 | $0.00 Strike: $109.35 | $0.00 |
DisclosureSEC source: 0001262976-19-000024 · wf-form4_155060484749631.xml · derivative · entry 3 Keane Robert S · CIK 0001337084 · Director · CEO, Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,116 Underlying: Ordinary Shares · 7,116 shares Expires 2029-02-15 F1 · derivative.exercise_price: This dollar amount is the three-year moving average (3YMA) on the date of grant, which is the baseline against which the compound annual growth rate (CAGR) of the 3YMA will be measured. F4 · derivative.exercise_date: Each PSU represents a right to receive between 0 and 2.5 Cimpress ordinary shares upon the satisfaction of both (A) service-based vesting and (B) performance conditions relating to the CAGR of the 3YMA. The service-based vesting condition is that 50% of the original number of PSUs vest on March 31, 2019 and the remaining 50% vest on June 30, 2019 so long as the reporting person continues to be an eligible participant under Cimpress' 2016 Performance Incentive Plan on such vesting date. If the 3YMA CAGR equals or exceeds 11% on any of the sixth through tenth anniversaries of the grant date then the reporting person is entitled to receive a distribution of up to 2.5 Cimpress ordinary shares for each vested PSU on a sliding scale based on the actual CAGR performance. Read SEC document |
| February 15, 2019 Filed Feb 19, 2019 19:34 UTC | CIMPRESS plc CMPR · Entity 4457 | GrantPerformance Share Units · Derivative | 1,143 | $0.00 Strike: $109.35 | $0.00 |
DisclosureSEC source: 0001262976-19-000024 · wf-form4_155060484749631.xml · derivative · entry 2 Keane Robert S · CIK 0001337084 · Director · CEO, Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,143 Underlying: Ordinary Shares · 1,143 shares Expires 2029-02-15 F1 · derivative.exercise_price: This dollar amount is the three-year moving average (3YMA) on the date of grant, which is the baseline against which the compound annual growth rate (CAGR) of the 3YMA will be measured. F3 · derivative.exercise_date: Each PSU represents a right to receive between 0 and 2.5 Cimpress ordinary shares upon the satisfaction of both (A) service-based vesting and (B) performance conditions relating to the CAGR of the 3YMA. The service-based vesting condition is that 25% of the original number of PSUs vest on each November 12 of 2019 through 2022 so long as the reporting person continues to be an eligible participant under Cimpress' 2016 Performance Incentive Plan on such vesting date. If the 3YMA CAGR equals or exceeds 11% on any of the sixth through tenth anniversaries of the grant date then the reporting person is entitled to receive a distribution of up to 2.5 Cimpress ordinary shares for each vested PSU on a sliding scale based on the actual CAGR performance. Read SEC document |
| February 15, 2019 Filed Feb 19, 2019 19:34 UTC | CIMPRESS plc CMPR · Entity 4457 | GrantPerformance Share Units · Derivative | 349 | $0.00 Strike: $109.35 | $0.00 |
DisclosureSEC source: 0001262976-19-000024 · wf-form4_155060484749631.xml · derivative · entry 1 Keane Robert S · CIK 0001337084 · Director · CEO, Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 349 Underlying: Ordinary Shares · 349 shares Expires 2029-02-15 F1 · derivative.exercise_price: This dollar amount is the three-year moving average (3YMA) on the date of grant, which is the baseline against which the compound annual growth rate (CAGR) of the 3YMA will be measured. F2 · derivative.exercise_date: Each performance share unit (PSU) represents a right to receive between 0 and 2.5 Cimpress ordinary shares upon the satisfaction of both (A) service-based vesting and (B) performance conditions relating to the CAGR of the 3YMA. The service-based vesting condition is that 100% of the PSUs vest on June 30, 2019 so long as the reporting person continues to be an eligible participant under Cimpress' 2016 Performance Incentive Plan on the vesting date. If the 3YMA CAGR equals or exceeds 11% on any of the sixth through tenth anniversaries of the grant date then the reporting person is entitled to receive a distribution of up to 2.5 Cimpress ordinary shares for each vested PSU on a sliding scale based on the actual CAGR performance. Read SEC document |
| August 15, 2018 Filed Aug 16, 2018 20:56 UTC | CIMPRESS plc CMPR · Entity 4457 | GrantPerformance Share Units · Derivative | 58,799 | $0.00 Strike: $102.68 | $0.00 |
DisclosureSEC source: 0001262976-18-000064 · wf-form4_153445297518139.xml · derivative · entry 1 Keane Robert S · CIK 0001337084 · CEO, President · Chairman of Management Board 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,799 Underlying: Ordinary Shares · 58,799 shares Expires 2028-08-15 F1 · derivative.exercise_price: This dollar amount is the three-year moving average daily price per share of Cimpress' ordinary shares ("3YMA") on the date of grant, which is the baseline against which the compound annual growth rate ("CAGR") of the 3YMA will be measured. F2 · derivative.exercise_date: Each performance share unit (PSU) represents a right to receive between 0 and 2.5 Cimpress ordinary shares upon the satisfaction of both (A) service-based vesting and (B) performance conditions relating to the CAGR of the 3YMA. The service-based vesting condition is that 25% of the original number of PSUs vest on each June 30 of 2019 through 2022 so long as the reporting person continues to be an eligible participant under Cimpress' 2016 Performance Incentive Plan on such vesting date. If the 3YMA CAGR equals or exceeds 11% on any of the sixth through tenth anniversaries of the grant date then the reporting person is entitled to receive a distribution of up to 2.5 Cimpress ordinary shares for each vested PSU on a sliding scale based on the actual CAGR performance. Read SEC document |
| May 01, 2018 Filed May 3, 2018 20:36 UTC | CIMPRESS plc CMPR · Entity 4457 | Exercise / conversionOption (right to buy) · Derivative | 166,659 | $0.00 Strike: $34.87 | $0.00 |
DisclosureSEC source: 0001209191-18-027654 · doc4.xml · derivative · entry 12 Keane Robert S · CIK 0001337084 · CEO, President · Chairman of Management Board 10b5-1 filing: Not disclosed Ownership: Indirect · By The Western Irrevocable Trust Disclosed balance after: 0 Underlying: Ordinary Shares · 166,659 shares Expires 2018-05-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the reporting person on November 27, 2017. F2 · kind: Option exercised in full due to expiration on May 2, 2018. F5 · derivative.exercise_date: This option became exercisable as to 25% of the original number of shares on the Exercisable Date shown on Table II, and as to an additional 6.25% of the original number of shares at the end of each successive three-month period thereafter. Read SEC document |
| May 01, 2018 Filed May 3, 2018 20:36 UTC | CIMPRESS plc CMPR · Entity 4457 | Exercise / conversionOption (right to buy) · Derivative | 166,659 | $0.00 Strike: $34.87 | $0.00 |
DisclosureSEC source: 0001209191-18-027654 · doc4.xml · derivative · entry 11 Keane Robert S · CIK 0001337084 · CEO, President · Chairman of Management Board 10b5-1 filing: Not disclosed Ownership: Indirect · By The Eastern Irrevocable Trust Disclosed balance after: 0 Underlying: Ordinary Shares · 166,659 shares Expires 2018-05-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the reporting person on November 27, 2017. F2 · kind: Option exercised in full due to expiration on May 2, 2018. F5 · derivative.exercise_date: This option became exercisable as to 25% of the original number of shares on the Exercisable Date shown on Table II, and as to an additional 6.25% of the original number of shares at the end of each successive three-month period thereafter. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.